Biogenic Nanoparticles for Cancer Theranostics

Erscheinungsjahr 2021
ISBN: 978-0-12-821467-1
Verlag: William Andrew Publishing

Buch, Englisch, 284 Seiten, Format (B × H): 191 mm x 235 mm, Gewicht: 590 g

Biogenic Nanoparticles for Cancer Theranostics outlines the synthesis of biogenic nanoparticles to become cancer theranostic agents. The book also discusses their cellular interaction and uptake, pharmacokinetics, biodistribution, drug delivery efficiency, and other biological effects. Additionally, the book explores the mechanism of their penetration in cancerous tissue, its clearance, and its metabolism. Moreover, the in vitro and in vivo toxicological effects of biogenic nanoparticles are discussed. This book is an important reference source for materials scientists and biomedical scientists who are looking to increase their understanding of how biogenic nanoparticles are being used for a range of cancer treatment types.

Metal nanoparticles have traditionally been synthesized by classical physico-chemical methods which have many drawbacks, such as high energy demand, high cost and potential ecotoxicity. As a result, the biosynthesis of metal nanoparticles is gaining increasing prominence. Biosynthesis approaches to metal nanoparticles are clean, safe, energy efficient and environment friendly.

Zielgruppe

Materials scientists, biomedical scientists, cancer researchers.

Autoren/Hrsg.

Ahmad, Irshad

Ayaz, Muhammad

Khalil, Ali Talha

Mukherjee, Sudip

Ovais, Muhammad

Fachgebiete

• Technische Wissenschaften Maschinenbau | Werkstoffkunde Technische Mechanik | Werkstoffkunde Materialwissenschaft: Biomaterialien, Nanomaterialien, Kohlenstoff
• Technische Wissenschaften Sonstige Technologien | Angewandte Technik Medizintechnik, Biomedizintechnik
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Medizintechnik, Biomedizintechnik, Medizinische Werkstoffe

Inhaltsverzeichnis

1. Nanotechnology for cancer drug design, delivery, and theranostics applications

2. Biogenic nanoparticles: synthesis, mechanism, characterization, and applications

3. Phytonanotechnology: a greener approach for biomedical applications

4. Microbial enzymes-mediated biosynthesis of metal nanoparticles

5. Green nanotechnology: isolation of bioactive molecules and modified approach of biosynthesis

6. Green synthesis of inorganic nanoparticles and their cancer theranostics applications

7. Biosynthesized silver nanoparticles in cancer theranostics applications

8. Green-synthesized nanoparticles for fluorescence bioimaging and diagnostic applications

9. Bioinspired nanoparticles-based drug delivery systems for cancer theranostics

10. Mechanisms underlying the anticancer applications of biosynthesized nanoparticles

11. Progress, challenges, and future opportunities for green nanomaterials as cancer nanomedicine

Über Autor(innen)

Ahmad, Irshad
Irshad Ahmad is Associate Professor of Life Sciences Department at King Fahd University of Petroleum & Minerals, Saudi Arabia. His research focuses in the area of green nanobiotechnology and cellular metabolics.

Mukherjee, Sudip
Sudip Mukherjee is a Research Fellow in Bioengineering at Rice University, USA. His research focuses on developing novel platforms of next generation therapeutics and diagnostics to improve the treatment of human diseases.

Khalil, Ali Talha
Ali Talha Khalil is an Assistant Professor (Molecular Biology), in the Department of Pathology, Lady Reading Hospital - Medical Teaching Institution, located in Peshawar, Pakistan. His research focuses on nanobiotechnological approaches to answer pressing challenges in health, environment and industry.

Ayaz, Muhammad
Muhammad Ayaz is a Lecturer at the Department of Pharmacy, University of Malakand, Pakistan. His research focuses on nanomaterials for drug delivery.

Ovais, Muhammad
Muhammad Ovais is a Research Scientist at the CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center of Excellence in Nanoscience, National Center for Nanoscience and Technology (NCNST), China. His research focuses on nanomedicine and cancer theranostics.
Dr. Ovais received his Ph.D. with distinction from CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of China. His research interests are in nanomedicines, biomaterials, immuno-engineering, and nanocatalytic medicine. He is the recipient of over 30 international awards, has authored over 50 journal articles and book chapters in journals such as Advanced Materials, NanoToday, Nanomedicine-Future Medicine, and Science China Chemistry.